Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit

Nephrology Dialysis Transplantation

Volumn 29, Issue 1, 2014, Pages 73-80

  Doi, Kent ^a   Noiri, Eisei ^a   Nangaku, Masaomi ^a   Yahagi, Naoki ^a   Jayakumar, Calpurnia ^b   Ramesh, Ganesan ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

acute kidney injury; AKI progression; biomarker; mixed ICU; semaphorin 3A

Indexed keywords

ALBUMIN; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; L TYPE FATTY ACID BINDING PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SEMAPHORIN 3A; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; URINALYSIS;

ACUTE KIDNEY INJURY; AKI PROGRESSION; BIOMARKER; MIXED ICU; SEMAPHORIN 3A;

ACETYLGLUCOSAMINIDASE; ACUTE KIDNEY INJURY; ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CRITICAL CARE; CRITICAL ILLNESS; DISEASE PROGRESSION; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-18; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEMAPHORIN-3A; SEPSIS;

EID: 84892693258     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft414     Document Type: Article

References (33)

1. Bennett M, Dent CL, Ma Q et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3: 665-673
2. Hirsch R, Dent C, Pfriem H et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007; 22: 2089-2095
3. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associ-ated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238
4. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6: 1639-1645
5. Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70: 199-203
6. Doi K, Negishi K, Ishizu T et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 2011; 39: 2464-2469
7. NOIRI E, Doi K, Negishi K et al. Urinary fatty acid binding protein 1: an early predictive biomarker of kidney injury. Am J Physiol Renal Physiol 2009; 296: F669-679
8. Han WK, Bailly V, Abichandani R et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237-244
9. Jayakumar C, Ranganathan P, Devarajan P et al. Semaphorin 3A is a new early diagnostic biomarker of experimental and pediatric acute kidney injury. PLoS ONE 2013; 8: e58446
10. Kolodkin AL, Matthes DJ, Goodman CS. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75: 1389-1399
11. Roth L, Koncina E, Satkauskas S et al. The many faces of sema-phorins: from development to pathology. Cell Mol Life Sci 2009; 66: 649-666
12. Reidy K, Tufro A. Semaphorins in kidney development and disease: modulators of ureteric bud branching, vascular morphogenesis, and podocyte-endothelial crosstalk. Pediatr Nephrol 2011; 26: 1407-1412
13. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212
14. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992
15. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31
16. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655
17. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845
18. Bielenberg DR, Klagsbrun M. Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 2007; 26: 421-431
19. Kumanogoh A, Kikutani H. Immune semaphorins: a new area of semaphorin research. J Cell Sci 2003; 116: 3463-3470
20. Miao HQ, Klagsbrun M. Neuropilin is a mediator of angiogen-esis. Cancer Metastasis Rev 2000; 19: 29-37
21. Tapia R, Guan F, Gershin I et al. Semaphorin3a disrupts podo-cyte foot processes causing acute proteinuria. Kidney Int 2007; 73: 733-740
22. Russell JA, Singer J, Bernard GR et al. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 2000; 28
23. Koyner JL, Garg AX, Coca SG et al. Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 2012; 23: 905-914
24. Kashani K, Al Khafaji A, Ardiles T et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17: R25
25. Yamamoto T, NOIRI E, Ono Y et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18: 2894-2902
26. Doi K, Katagiri D, Negishi K et al. Mild elevation of urinary bio-markers in prerenal acute kidney injury. Kidney Int 2012; 82: 1114-1120
27. Bagshaw S, Bennett M, Haase M et al. Plasma and urine neutro-phil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intens Care Med 2010; 36: 452-461
28. Wheeler DS, Devarajan P, Ma Q et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008; 36: 1927-1030
29. Doi K, NOIRI E, Maeda-Mamiya R et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med 2010; 38: 2037-2042
30. Shusterman N, Strom BL, Murray TG et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epide-miologic study. Am J Med 1987; 83: 65-71
31. Allgren RL, Marbury TC, Rahman SN et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997; 336: 828-834
32. Hirschberg R, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999; 55: 2423-2432
33. Siew ED, Matheny ME, Ikizler TA et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 2010; 77: 536-542